Red Light Boosts Knee Stem Cell Growth Through Calcium Channel Activation
Near-infrared and red light at optimal doses stimulates meniscus stem cell proliferation via TRPV1 calcium signaling, opening new doors for joint repair.
Summary
Researchers exposed human meniscus-derived stem cells (MeSCs) to LED light at four wavelengths and four energy densities, finding that red and near-infrared light (700–710 nm and 1064 nm) at 3–30 J/cm² enhanced cell proliferation and mitochondrial health, with the strongest effect at 15 J/cm². The key mechanism was activation of the TRPV1 calcium channel, which elevated intracellular calcium and reactive oxygen species (ROS). Critically, cytochrome C oxidase activity and nitric oxide levels did not change, ruling out two commonly proposed PBM mechanisms. Blocking TRPV1 abolished the proliferative benefits, confirming it as the primary driver. These findings could improve stem cell pretreatment protocols for meniscus repair therapies.
Detailed Summary
Meniscus injuries are common, notoriously difficult to repair, and often progress to osteoarthritis and joint replacement. Stem cell therapy using meniscus-derived stem cells (MeSCs) is promising, but harvesting sufficient viable cells remains a bottleneck. Photobiomodulation (PBM)—low-level light therapy using LEDs or lasers—has shown potential for enhancing stem cell behavior, yet its mechanisms in MeSCs were poorly understood.
This study systematically exposed human MeSCs (isolated from a male donor aged 66–75 undergoing knee arthroplasty) to LED light across four wavelengths (400–405 nm violet, 500–505 nm green, 700–710 nm red, and 1064 nm near-infrared) and four energy densities (3, 15, 30, and 60 J/cm²). A comprehensive panel of outcomes was measured: intracellular calcium (Ca²⁺), cytochrome C oxidase (CCO) activity, nitric oxide (NO) concentration, cell viability (MTT assay), mitochondrial membrane potential, reactive oxygen species (ROS) via ELISA, and cell proliferation by counting.
The clearest finding was a wavelength- and dose-dependent bifurcation in outcomes. Red (700–710 nm) and near-infrared (1064 nm) light at 3, 15, and 30 J/cm² significantly promoted MeSC proliferation and preserved mitochondrial membrane potential, with 15 J/cm² producing the most pronounced benefit. By contrast, violet (400–405 nm) and green (500–505 nm) light at all doses, and all wavelengths at 60 J/cm², impaired mitochondrial function and reduced proliferative capacity—demonstrating a clear biphasic (hormetic) dose response.
Mechanistically, PBM increased intracellular Ca²⁺ and ROS in proportion to energy density across all wavelengths. However, CCO activity and NO concentrations did not change under any condition tested, directly contradicting two of the four canonical PBM hypotheses. When TRPV1 (transient receptor potential vanilloid 1), a heat- and light-sensitive calcium channel, was pharmacologically inhibited, PBM-induced Ca²⁺ and ROS elevations were abolished, as were the associated changes in cell proliferation. This implicates TRPV1-Ca²⁺-ROS as the central signaling axis mediating PBM effects in MeSCs—distinct from CCO- or NO-driven mechanisms proposed for other cell types.
These results are significant for regenerative medicine: optimized PBM pretreatment (red or NIR light at ~15 J/cm²) could enhance MeSC expansion ex vivo before injection therapy, potentially improving outcomes for meniscal repair. The identification of TRPV1 as the gatekeeper also opens pharmacological angles for further optimization. Caveats include the single-donor, single-sex cell source, an in vitro-only design, and the absence of downstream functional assays like chondrogenic differentiation post-PBM.
Key Findings
- Red (700–710 nm) and near-infrared (1064 nm) light at 15 J/cm² maximally boosted MeSC proliferation and mitochondrial health.
- Violet and green wavelengths, and all wavelengths at 60 J/cm², reduced mitochondrial function and cell proliferation.
- TRPV1 calcium channel activation—not cytochrome C oxidase or nitric oxide—is the primary PBM mechanism in MeSCs.
- Blocking TRPV1 abolished PBM-induced calcium and ROS elevation and prevented proliferation changes.
- Intracellular Ca²⁺ and ROS rose dose-dependently across all wavelengths, independent of CCO activity or NO levels.
Methodology
Human MeSCs from a single male donor (66–75 years, knee osteoarthritis) were irradiated once with LED light at four wavelengths and four energy densities (n=6 independent replicates per condition). Outcomes included MTT viability, cell counting, Ca²⁺ colorimetry, CCO activity, NO (Griess method), ROS (ELISA), and mitochondrial membrane potential fluorescence. TRPV1 inhibition experiments were used to confirm mechanistic attribution.
Study Limitations
Cells were sourced from a single male donor with osteoarthritis, limiting generalizability across age, sex, and disease states. The study is entirely in vitro, with no animal or clinical validation of proliferative benefits translating to tissue repair. Downstream functional outcomes such as chondrogenic differentiation capacity post-PBM were not assessed.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: